Articles
-
Don’t Let the New Kidney Health Initiative Fade from View
As a kidney doctor and health policy researcher, I am surprised that President Donald Trump’s initiative to remake kidney treatment has not gotten more attention. We need to keep paying attention because so much is at stake.
Categorized in -
Rep. Ruiz’s Arbitration Proposal for Surprise Billing (H.R. 3502) Would Lead to Much Higher Costs and Deficits
USC-Brookings Schaeffer Initiative researchers review the latest proposed legislation from Representative Ruiz on surprise medical billing.
Categorized in -
‘Meaningful Use’ of Cost-Measurement Systems — Incentives for Health Care Providers
How can lawmakers build on the U.S. Health Information Technology for Economic and Clinical Health (HITECH) Act of 2009? USC-Brookings Schaeffer Initiative Director Paul Ginsburg shares his thoughts in The New England Journal of Medicine.
Categorized in -
CMS’s International Pricing Model for Medicare Part B Drugs: Implementation Issues
To lower the Part B portion of drug spending, the Trump Administration has proposed a demonstration project tying Medicare reimbursement for outpatient, physician-administered drugs to international prices. Paul Ginsburg and Steven Lieberman explore the potential consequences of such a rule.
Categorized in -
We Need More Primary Care Physicians: Here’s Why and How
USC-Brookings Schaeffer Initiative researchers explain why we need more primary care physicians and how to close the gap between primary care and specialty medicine.
Categorized in -
Federal Surprise Billing Legislation Does Not Violate the Constitution
USC-Brookings Schaeffer Initiative Fellow Christen Young breaks down the Constitutional challenges raised against surprise billing legislation and why they are likely to fail.
Categorized in -
Book Review: Immunotherapy’s Promise
Jakub Hlávka reviews a new book on the future of cancer treatments that he writes “[offers] a hopeful account of medical research that could, one day, save even more lives.”
Categorized in -
Do Lower Readmissions at Penalized Hospitals Signify an Effective Policy or Simply a Statistical Anomaly?
A new analysis finds at least three quarters of the improvement in readmission rates by hospitals who had poor baseline performance was due to regression to the mean (i.e. statistical luck) rather than the policy.
Categorized in -
Schaeffer Center Fellow Wins Top Student Award of the American Society of Health Economists
Eunhae Shin, 2019 USC doctoral degree graduate and USC Schaeffer Center pre-doctoral fellow, received the 2019 Student Paper Award from the American Society of Health Economists (ASHEcon) at the society’s annual meeting in Washington, DC on June 24.
-
Untangling Differences in Quality of Care in Medicare Advantage Versus Traditional Medicare Programs
Neeraj Sood and a colleague discuss measuring and interpreting differences in quality of care for Medicare Advantage beneficiaries compared to those enrolled in traditional fee-for-service Medicare.
Categorized in